Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 System diseases and visual evoked potential diagnosis in neurology: changes due to synaptic malfunction.

× No keyword cloud information.

13 in total

1. Short-term neurophysiological monitoring in multiple sclerosis bouts. Evaluation of steroid treatment.

Authors: V Scaioli; C Milanese; A Salmaggi; L LaMantia; A Campi; M Eoli; F Panzica
Journal: Ital J Neurol Sci Date: 1992-03

2. Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques.

Authors: D Gambi; T Fulgente; D Melchionda; M Onofrj
Journal: Ital J Neurol Sci Date: 1996-02

3. Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans.

Authors: M Onofrj; M F Ghilardi; M Basciani; D Gambi
Journal: J Neurol Neurosurg Psychiatry Date: 1986-10 Impact factor: 10.154

Review 4. Some comments on the clinical use of evoked potentials.

Authors: S L Notermans; E J Colon
Journal: Eur Arch Psychiatry Neurol Sci Date: 1986

5. The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Authors: Ozlem Ozsoy; Gamze Tanriover; Narin Derin; Nimet Uysal; Necdet Demir; Burcu Gemici; Ceren Kencebay; Piraye Yargicoglu; Aysel Agar; Mutay Aslan
Journal: Neurotox Res Date: 2011-01-14 Impact factor: 3.911

Review 6. MEG: new techniques.

Authors: V Pizzella; G L Romani; S N Erné; P M Rossini
Journal: Brain Topogr Date: 1993 Impact factor: 3.020

System diseases and visual evoked potential diagnosis in neurology: changes due to synaptic malfunction.

1. Short-term neurophysiological monitoring in multiple sclerosis bouts. Evaluation of steroid treatment.

2. Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques.

3. Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans.

Review 4. Some comments on the clinical use of evoked potentials.

5. The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.

Review 6. MEG: new techniques.

7. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy.

8. Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects.

9. Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients.

10. Multiple intracranial enterogenous cysts.